Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma FibrosisSei Muraoka(Toho University), Pei‐Suen Tsou(University of Michigan)Arthritis & RheumatologyAugust 22, 202410.1002/art.42973Cited by 13SaveCiteExport RISWatch citationsRelated PapersScleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines|Lara D. Veeken|2015|28Identification of Cysteine‐Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma|Arthritis & Rheumatology|2019|24Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma|JCI Insight|2022|22